Save time and get answers to complex questions with AI chat
Is clarinex off patent?Pramlintide fda approval date?What is dabrafenib mesylate msn patent issue?Are there income restrictions for lipitor's patient program?Guselkumab loss of exclusitivy?
See the DrugPatentWatch profile for xeljanz
Prices vary a lot by country, dose, and insurance. Here’s a quick guide: - In the United States, the list price for Xeljanz (tofacitinib) at the common rheumatoid arthritis dose (5 mg tablets taken twice daily, i.e., 60 tablets per 30 days) is generally in the range of about $4,000–$7,000 per month before any discounts or insurance coverage. - Your out-of-pocket with insurance can be much lower (often a few hundred dollars or less per month for many plans), and manufacturers sometimes offer patient assistance programs to reduce costs. - Dosing affects cost: - RA maintenance: 5 mg tablets taken twice daily = ~60 tablets per month. - UC or other regimens can require more tablets (e.g., induction dosing like 10 mg twice daily = ~120 tablets per month), which raises the monthly cost correspondingly. - Outside the US, prices differ by country and healthcare system, sometimes several thousand pounds/euros per month or equivalent. If you’d like a more precise estimate, I can tailor it if you share: - Your country/region - The exact dose you’re taking or plan to take - Whether you have insurance or a prescription discount program I can also point you to ways to reduce cost (e.g., insurance approval processes, manufacturer patient assistance, or discount programs).
Other Questions About Xeljanz :